The second in a two-part series highlighting Connecticut’s bioscience footprint.
Co-organized by BioCT, PhRMA and the Bipartisan Bioscience Caucus, please join us for the second in a two part series highlighting Connecticut’s bioscience footprint.
During our discussion we will learn about the scientific breakthroughs that participating companies have made in the fight against the COVID-19 pandemic, along with the impact the industry’s work has made in Connecticut.
Featuring presenters from Alexion, Boehringer Ingelheim and Pfizer
Moderated by Bristol Myers Squibb